B1YJV2 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeihe2ogrmgd6fwcxqgjvwvxzyw5srzqm7v3esraxudioxob5fmgehm/metadata.json

IPFS of structure file:

bafybeiam7tocqjkaj6few2lnny7yrmol5jpmpihzwvm6dn6pnl2ce2pa6a/AF-B1YJV2-F1-model_v2.pdb

First NFT owner address (eip-55):

0xd91633319BDB0a92cbC4f08DeA734Bf74C030064

First NFT owner address (bech32):

genesis1mytrxvvmmv9f9j7y7zx75u6t7axqxqry8u4g92

Current NFT ID #166621 owner (web3):

0xd91633319BDB0a92cbC4f08DeA734Bf74C030064

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
166621
Accession (UniProt):
B1YJV2
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Exiguobacterium sibiricum (strain DSM 17290 / CIP 109462 / JCM 13490 / 255-15)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B1YJV2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B1YJV2|HEM1_EXIS2 Glutamyl-tRNA reductase OS=Exiguobacterium sibiricum (strain DSM 17290 / CIP 109462 / JCM 13490 / 255-15) OX=262543 GN=hemA PE=3 SV=1 MHIVVVGLNNKTAPVSIREQVSFGEHEMKGAVVALRDEKSIFESVIVSTCNRTELYVVTDQPHTGRYYTKRFLANWFGLTMEELEPYLFIHEGFDAMKHLFRVTSGLDSMIVGETQILGQVKTSFFTAQKLETTGTVFNKLFKEAVTLAKRAHAETGIGENAVSVSAAAVTLAEQLLGSLEDKSIVVIGAGETGELTTLNLYEAGARDITVFNRTLAKAEEVANRFEGSAHSINEMQCGLLRADIVISSTGAKRAIIKREDIAAAQLFRSDRPFLLIDIAVPRDIEPTAGDLPGVHLYDVDDLTSIVQQNMAERMKEAAKIERRIEAAIAEFEGWMTTLGVVPIITELRDQSLKIQQETMQSLERKLPNMTNREKTVIGKHMKSIINQLLREPLSYIKDAAAKPDAEQRIAQFMDTFALDEELFDSAAEEMVLQEETTAERKAVNR

MOLNFT AF v1_w

NFT data

MOLNFT B1YJV2 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience